CrushSCI.com
433.4Average days
374.5Median days
160Fastest days
819Longest days
2612025 publications

Paper Review Records

All Paper Review Records

12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

560 days

TIGIT and PD-L1 co-blockade promotes dendritic cell-dependent production of non-exhausted CD8+ T cells

Authors
Ellen Duong; Thomas D. Wu; Charles W. Tran; Conrad Foo; Karl L. Banta; Lili Adams; Katherine Nutsch; Aditya A. Anand; Catherine B. Carbone; Alan Gutierrez; Yajun Chestnut; Camille-Charlotte Balança; William H. Tomaszewski; Žaneta Andrusivová; Jian Jiang; Anthony C. Antonelli; Jérémie Decalf; Jeanne Cheung; Shiuh-Ming Luoh; Sandra Rost; Lisa M. McGinnis; Milena Hornburg; Eugene Y. Chiang; Soyoung A. Oh; Ira MellmanShow moreShow less
Affiliations
Genentech, South San Francisco, CA, USAShow moreShow less
Source PDF DOI Publisher page
683 days

Temporal analyses of immune responses in sepsis reveal asynchrony between clinical stage of illness and immune states

Authors
Matthew Fish; Jennifer Rynne; Emma Timms; Aislinn Jennings; Carolynn Lam; Gill Arbane; Neus Novellas; Sara Campos; Barney Sanderson; Paolo Bosco; Gianluca Lucchese; Richard Ellis; Cynthia Bishop; Katrina Todd; Yasmeen Ghnewa; Mervyn Singer; Chad Swanson; Manu Shankar-HariShow moreShow less
Affiliations
Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King’s College London, London SE1 9RT, UK; Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, 4-5 Little France Drive, Edinburgh, UK; Department of Intensive Care Medicine, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London, UK; Cardiovascular Department, Guy’s and St Thomas’ NHS Foundation Trust, St Thomas’ Hospital, London, UK; Advanced Cytometry Platform (Flow Core), Research and Development Department at Guy’s and St Thomas' NHS Foundation Trust, Guy’s Hospital, London SE1 9RT, UK; University of East London, London, UK; Bloomsbury Institute of Intensive Care Medicine, University College London, London WC1E 6BT, UK; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London, London SE1 9RT, UK; Centre for Critical Illness Research, School of Immunology and Microbial Sciences, King’s College London, London SE1 9RT, UKShow moreShow less
Source PDF DOI Publisher page
429 days

Single-allele chromatin tracing reveals cytokine-dependent super-enhancer repositioning in CD4+ T cells

Authors
Atishay Jay; Yeqiao Zhou; Sora Yoon; Bereketab N. Abeje; Aditi Chandra; Michael F. Michieletto; Julia Wald; Jorge Henao-Mejia; Arjun Raj; Robert B. Faryabi; Golnaz VahediShow moreShow less
Affiliations
Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Epigenetics Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Bioengineering, University of Pennsylvania School of Engineering and Applied Science, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USAShow moreShow less
Source PDF DOI Publisher page
160 days

GPCR-Gα13 signaling regulates survival of intestinal intraepithelial CD8+ lymphocytes through migration to cytokine-rich niches

Authors
Zachary M. Earley; Anshul Rao; Longhui Qiu; Konrad Knöpper; Fanglue Peng; Norihide Jo; Ananya Krishnapura; Wioletta Lisicka; Hanna Taglinao; Jinping An; Ying Xu; Li V. Yang; Dan Liu; Mark R. Looney; Jason G. CysterShow moreShow less
Affiliations
Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Medicine and Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Medicine, University of Chicago, Chicago, IL, USA; Division of Hematology/Oncology, Department of Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, NC, USAShow moreShow less
Source PDF DOI Publisher page
362 days

UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes

Authors
Jennifer A. Lo; Inbal Rachmin; Jessica L. Flesher; Xunwei Wu; Akinori Kawakami; Miroslav Hejna; Judith R. Boozer; Nhu Nguyen; Andrew D. King; Yawen Ji; Sharon Germana; Lajos V. Kemeny; Anita A.J. van der Sande; Jeffrey B. Cheng; Michal Lotem; Torrey R. Utne; Yao Zhan; Elisabeth M. Roider; Nisma Mujahid; Elizabeth H. Byrne; Shailbala Singh; Manoubia Saidani; Sabrina Martineau; Nathalie Holic; Christine Baldeschi; Cécile Martinat; Gordon J. Freeman; Nir Hacohen; Keith T. Flaherty; Genevieve M. Boland; Jun S. Song; Arlene H. Sharpe; Shadmehr Demehri; Cassian Yee; Jennifer Allouche; David E. FisherShow moreShow less
Affiliations
Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA; Department of Dermatology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Dermatology, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan; Department of Physics, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA; Department of Stomatology, Central Hospital Affiliated to Shandong First Medical University, Jinan 250013, Shandong, China; HCEMM-SU Translational Dermatology Research Group, Semmelweis University, Budapest 1085, Hungary; Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest 1094, Hungary; Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine, Semmelweis University, Budapest 1085, Hungary; MTA-SE Lendület “Momentum” Dermatology Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest 1085, Hungary; Department of Dermatology, University of California, San Francisco, San Francisco, CA 94143, USA; Dermatology Service, San Francisco Veterans Administration Health Care System, San Francisco, CA 94121, USA; Lautenberg Center for Immunology and Cancer Research, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; Center for Melanoma and Cancer Immunotherapy, Sharett Institute of Oncology, Jerusalem 91120, Israel; Hadassah Cancer Research Institute, Hadassah Hebrew University Medical Center, Jerusalem 91120, Israel; Department of Dermatology, University Hospital of Basel, 4031 Basel, Switzerland; Department of Dermatology, University of Utah, Salt Lake City, UT 84132, USA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; IStem, CECS, Corbeil-Essonnes 91100, France; Université Paris-Saclay, Université d’Evry, Inserm, IStem, UMR861, Corbeil-Essonnes 91100, France; Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02142, USA; Mass General Brigham Cancer Institute, Boston, MA 02114, USA; Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA; Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Gene Lay Institute of Immunology and Inflammation of Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute of Cancer Immunotherapy, San Francisco, CA 94129, USAShow moreShow less
Source PDF DOI Publisher page
371 days

Coordinated transcriptional networks program organelle expansion and metabolic flows for high endothelial morphology and function

Authors
Yuhan Bi; Kevin Brulois; Aiman Ayesha; Menglan Xiang; Romain Ballet; Borja Ocón; Theresa Dinh; Nicole Lazarus; Manali Kunte; Griselda Ramos; Florea Lupu; Jonathan H. Lin; Eugene C. Butcher; Junliang PanShow moreShow less
Affiliations
Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; VA Palo Alto Health Care System, Palo Alto, CA, USA; Palo Alto Veterans Institute for Research, Palo Alto, CA, USA; Oklahoma Medical Research Foundation, Oklahoma City, OK, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Immunity take to review a manuscript?

As of 2026-11-19, CrushSCI has 12 complete review records for Immunity. The fastest paper went from submission to acceptance in 160 days (GPCR-Gα13 signaling regulates survival of intestinal intraepithelial CD8+ lymphocytes through migration to cytokine-rich niches, received 2026-02-19, accepted 2026-07-29); the slowest took 819 days. The average is 433.4 days and the median is 374.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.